UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies

European urology, 2018-11, Vol.74 (5), p.633-643

2018

Volltextzugriff (PDF)

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.17-30

2014

Volltextzugriff (PDF)

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

European urology, 2020-01, Vol.77 (1), p.119-128

2020

Volltextzugriff (PDF)

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

BJU international, 2017-10, Vol.120 (4), p.562-575

2017

Volltextzugriff (PDF)

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

European urology, 2019-03, Vol.75 (3), p.464-476

2019

Volltextzugriff (PDF)

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

BJU international, 2015-06, Vol.115 (6), p.968-977

2015

Volltextzugriff (PDF)

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

European urology focus, 2019-03, Vol.5 (2), p.280-289

2019

Volltextzugriff (PDF)

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

BJU international, 2017-11, Vol.120 (5), p.611-622

2017

Volltextzugriff (PDF)

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

Neurourology and urodynamics, 2013-11, Vol.32 (8), p.1116-1122

2013

Volltextzugriff (PDF)

The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis

European urology, 2005-07, Vol.48 (1), p.5-26

2005

Volltextzugriff (PDF)

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Neurourology and urodynamics, 2012-01, Vol.31 (1), p.13-21

2012

Volltextzugriff (PDF)

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S6-S13

Chapple, Christopher

2014

Volltextzugriff (PDF)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

International journal of clinical practice (Esher), 2017-05, Vol.71 (5), p.e12944-n/a

2017

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement

World journal of urology, 2013-08, Vol.31 (4), p.997-1008

2013

Volltextzugriff (PDF)

Comparison of fesoterodine and tolterodine in patients with overactive bladder

BJU international, 2008-11, Vol.102 (9), p.1128-1132

2008

Volltextzugriff (PDF)

The placebo effect in overactive bladder syndrome

Nature reviews. Urology, 2011-09, Vol.8 (9), p.495-503

2011

Volltextzugriff (PDF)

Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment

Urology (Ridgewood, N.J.), 2006-08, Vol.68 (2), p.3-8

2006

Volltextzugriff (PDF)

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

World journal of urology, 2015-05, Vol.33 (5), p.697-706

2015

Volltextzugriff (PDF)

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

BJU international, 2005-01, Vol.95 (1), p.81-85

2005

Volltextzugriff (PDF)

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

BJU international, 2010-11, Vol.106 (9), p.1332-1338

2010

Volltextzugriff (PDF)

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Expert opinion on pharmacotherapy, 2006-12, Vol.7 (17), p.2421-2434

Chapple, Christopher R

2006

Volltextzugriff (PDF)

Stress Incontinence Injection Therapy: What is Best for Our Patients?

European urology, 2005-10, Vol.48 (4), p.552-565

2005

Volltextzugriff (PDF)

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

European urology, 2006-05, Vol.49 (5), p.879-886

2006

Volltextzugriff (PDF)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

European urology, 2005-09, Vol.48 (3), p.488-494

2005

Volltextzugriff (PDF)

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S1-S1

Chapple, Christopher

2014

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

SpracheJapanisch

ThemaScience & Technology

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Humans
(43)
Urology & Nephrology
(37)
Female
(26)
Male
(23)
Middle Aged
(19)
Adult
(18)
Urinary Bladder, Overactive - Drug Therapy
(18)
Aged
(17)
Quality Of Life
(16)
Urinary Incontinence
(15)
Overactive Bladder
(13)
Double-Blind Method
(11)
Muscarinic Antagonists - Therapeutic Use
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Nephrology. Urinary Tract Diseases
(9)
Muscarinic Antagonists - Adverse Effects
(8)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement

Comparison of fesoterodine and tolterodine in patients with overactive bladder

The placebo effect in overactive bladder syndrome

Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Stress Incontinence Injection Therapy: What is Best for Our Patients?

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Aktive Filter

Suchergebnisse filtern